Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hohlfeld, R.
Right arrow Articles by Iglesias, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hohlfeld, R.
Right arrow Articles by Iglesias, A.

Neurology, Vol 45, Issue 6 S33-S38, Copyright © 1995 by American Academy of Neurology

VIEWS & REVIEWS

The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis

R Hohlfeld, E Meinl, F Weber, F Zipp, S Schmidt, S Sotgiu, N Goebels, R Voltz, S Spuler and A Iglesias
Department of Neuroimmunology, Max-Planck Institute of Psychiatry, Martinsried, Germany.

Autoimmune T cells play a key role as regulators and effectors of autoimmune disease. In multiple sclerosis (MS), activated T cells specific for myelin components or other locally expressed autoantigens enter the CNS and recognize their antigen(s) on local antigen- presenting cells. After local stimulation, the T cells produce a plethora of cytokines and inflammatory mediators that have profound effects on the local cellular environment, induce and recruit additional inflammatory cells, and contribute to myelin damage. An increasingly detailed knowledge of these processes will greatly facilitate the development of new immunotherapies. This article focuses on the role of T cells in MS. We provide a brief overview of the principles of T-cell immunology, discuss the experimental techniques available for studying T cells, address the role of T cells in the pathogenesis of MS, and highlight modern concepts for immunotherapy.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
L. Klotz, M. Schmidt, T. Giese, M. Sastre, P. Knolle, T. Klockgether, and M. T. Heneka
Proinflammatory Stimulation and Pioglitazone Treatment Regulate Peroxisome Proliferator-Activated Receptor {gamma} Levels in Peripheral Blood Mononuclear Cells from Healthy Controls and Multiple Sclerosis Patients
J. Immunol., October 15, 2005; 175(8): 4948 - 4955.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
D. C Mohr, S. L Hart, L. Julian, D. Cox, and D. Pelletier
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis
BMJ, March 27, 2004; 328(7442): 731.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Schmidt, E. Moric, M. Schmidt, M. Sastre, D. L. Feinstein, and M. T. Heneka
Anti-inflammatory and antiproliferative actions of PPAR-{gamma} agonists on T lymphocytes derived from MS patients
J. Leukoc. Biol., March 1, 2004; 75(3): 478 - 485.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J-M. Dayer
How T-lymphocytes are activated and become activators by cell-cell interaction
Eur. Respir. J., September 20, 2003; 22(44_suppl): 10S - 15s.
[Full Text] [PDF]

Home page
 Psychosom. Med.Home page
D. C. Mohr, S. L. Hart, and A. Goldberg
Effects of Treatment for Depression on Fatigue in Multiple Sclerosis
Psychosom Med, July 1, 2003; 65(4): 542 - 547.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.